Salud

¿Cuándo tendremos tratamientos contra covid-19 en Costa Rica? Esto responden autoridades y farmacéuticas

El Ministerio de Salud autorizó el uso de emergencia tanto del tratamiento de Pfizer como el de MSD, no obstante, ninguno de los dos se consigue hoy en el país

(FILES) This handout file photo obtained May 26, 2021, courtesy of Merck & Co, Inc. shows capsules of the investigational antiviral pill Molnupiravir. - The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill, Molnupiravir, for high risk adults, a day after a similar pill by Pfizer was given the green light. "Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni. (Photo by Handout / Merck & Co,Inc. / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
(FILES) This handout file photo obtained May 26, 2021, courtesy of Merck & Co, Inc. shows capsules of the investigational antiviral pill Molnupiravir. - The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill, Molnupiravir, for high risk adults, a day after a similar pill by Pfizer was given the green light. "Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni. (Photo by Handout / Merck & Co,Inc. / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS HANDOUT
‌
‌

‌

‌
‌

‌

‌